Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 87.20% | 74.88% | -195.84% | -203.47% | -2,647.58% |
| Total Depreciation and Amortization | 1.93% | 16.52% | -5.79% | -25.71% | -24.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -123.25% | -126.38% | 140.30% | 106.79% | 4,895.84% |
| Change in Net Operating Assets | 963.74% | 463.46% | 87.69% | 875.58% | -850.70% |
| Cash from Operations | 74.43% | -278.89% | -165.11% | -163.03% | -148.93% |
| Capital Expenditure | 27.67% | 31.58% | 21.94% | 19.92% | 1.39% |
| Sale of Property, Plant, and Equipment | 107.73% | 116.63% | 122.54% | -24.61% | -29.85% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.68% | -62.24% | -126.10% | -354.62% | -834.88% |
| Cash from Investing | 262.51% | 248.51% | 251.38% | 223.93% | -87.01% |
| Total Debt Issued | -26.11% | 0.20% | -9.97% | 38.69% | 153.24% |
| Total Debt Repaid | 12.48% | -1.40% | 21.93% | -15.58% | -95.03% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 47.07% | 47.07% | -477.25% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -319.87% | -27.44% | 87.07% | 77.60% | 326.45% |
| Cash from Financing | -217.26% | -33.07% | 164.16% | 170.28% | 195.20% |
| Foreign Exchange rate Adjustments | -80.57% | -96.59% | 406.95% | 310.43% | -70.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.38% | 64.64% | 231.27% | 204.06% | 83.48% |